These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21440548)

  • 1. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
    Abu Dayyeh BK; Yang M; Fuchs BC; Karl DL; Yamada S; Sninsky JJ; O'Brien TR; Dienstag JL; Tanabe KK; Chung RT;
    Gastroenterology; 2011 Jul; 141(1):141-9. PubMed ID: 21440548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
    Lok AS; Everhart JE; Wright EC; Di Bisceglie AM; Kim HY; Sterling RK; Everson GT; Lindsay KL; Lee WM; Bonkovsky HL; Dienstag JL; Ghany MG; Morishima C; Morgan TR;
    Gastroenterology; 2011 Mar; 140(3):840-9; quiz e12. PubMed ID: 21129375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Chen K; Wei Y; Yang H; Li B
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):251-5. PubMed ID: 21186997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.
    Wu J; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):595-600. PubMed ID: 23790025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
    Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
    BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
    JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
    Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH
    J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
    Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
    World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
    Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
    Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).
    Curto TM; Lagier RJ; Lok AS; Everhart JE; Rowland CM; Sninsky JJ;
    Pharmacogenet Genomics; 2011 Dec; 21(12):851-60. PubMed ID: 21946897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.